Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
Top Cited Papers
- 1 March 2014
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 383 (9921), 955-962
- https://doi.org/10.1016/s0140-6736(13)62343-0
Abstract
No abstract availableThis publication has 40 references indexed in Scilit:
- Efficacy and Safety of Apixaban Compared With Warfarin at Different Levels of Predicted International Normalized Ratio Control for Stroke Prevention in Atrial FibrillationCirculation, 2013
- Systematic Review and Adjusted Indirect Comparison Meta-Analysis of Oral Anticoagulants in Atrial FibrillationCirculation: Cardiovascular Quality and Outcomes, 2012
- Apixaban versus Warfarin in Patients with Atrial FibrillationThe New England Journal of Medicine, 2011
- Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial FibrillationCirculation, 2011
- Future directions of stroke prevention in atrial fibrillation: the potential impact of novel anticoagulants and stroke risk stratificationJournal of Thrombosis and Haemostasis, 2011
- Newly Identified Events in the RE-LY TrialThe New England Journal of Medicine, 2010
- Impact of Proteinuria and Glomerular Filtration Rate on Risk of Thromboembolism in Atrial FibrillationCirculation, 2009
- Use and Effectiveness of Warfarin in Medicare Beneficiaries With Atrial FibrillationStroke, 2006
- Measuring inconsistency in meta-analysesBMJ, 2003
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986